'Terrible dilemma': Toobin on FDA's Alzheimer treatment approval

CNN’s Jeffrey Toobin weighs in on the FDA’s approval of a new Alzheimer’s drug in June despite the FDA’s advisory committee concluding there wasn’t enough evidence to support the effectiveness of the treatment.